Log In
BCIQ
Print this Print this
 

LIV-2008b

  Manage Alerts
Collapse Summary General Information
Company Chiome Bioscience Inc.
DescriptionHuman mAb against tumor-associated calcium signal transducer 2 (TROP-2)
Molecular Target Tumor-associated calcium signal transducer 2 (TACSTD2) (TROP2)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$99.0M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/15/2016

$99.0M

Undisclosed

Undisclosed

Get a free BioCentury trial today